Search - tctmd.com

Displaying 961 - 980 of 2799

Sort: Relevancy | Date

Presentation TCT 2022

TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves

Presenter: Ali Azadani

September 19, 2022

Presentation TCT 2022

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

September 19, 2022

$TCT 708: Balloon ring fracture and transcatheter aortic valve-in-valve implantation into a failed Direct Flow Medical prosthesis: in-vitro benchmark tests and in-vivo treatment$

Presentation TCT 2022

TCT 708: Balloon ring fracture and transcatheter aortic valve-in-valve implantation into a failed Direct Flow Medical prosthesis: in-vitro benchmark tests and in-vivo treatment

Presenter: Axel Unbehaun

September 19, 2022

Presentation TCT 2022

First-in-Human Transfemoral Tricuspid Valve Replacement With an Innovative Transcatheter Heart Valve Replacement System (TriCares TOPAZ)

Presenter: Geraldine Ong

September 19, 2022

Presentation TCT 2022

Residual MR Post-TEER: Predictors of Long Term Success (and Late Failure)

Presenter: Rebecca Hahn

September 19, 2022

Presentation TCT 2022

Tailoring TEER: Imaging for Clip Selection and Technical Approaches (Based Upon Anatomic Considerations)

Presenter: Nadira Hamid

September 19, 2022

Presentation TCT 2022

Two-Stage Transcatheter Tricuspid Annuloplasty: Technology Description and First Human Case Demonstrating Concept Validation (Cardiac Implants)

Presenter: Mark Reisman

September 19, 2022

Presentation TCT 2022

My Personal Step-by-Step Imaging Algorithm for TEER Planning and Procedural Guidance

Presenter: Eustachio Agricola

September 19, 2022

Presentation TCT 2022

TEER Planning: Real-World Situations Where Multi-Modality Imaging Is Recommended (Case-Based)

Presenter: Joao L. Cavalcante

September 19, 2022

Presentation TCT 2022

TCT 423: Effect of low versus high mitral valve gradients on outcomes of functional and degenerative mitral valve disease post transcatheter edge to edge repair.

Presenter: Sumit Sohal

September 19, 2022

Presentation TCT 2022

Keynote Lecture: The Future of Diagnostic Imaging Modalities (Intra- and Extra-Vascular) and Implications for Transcatheter Therapies

Presenter: Patrick Washington Serruys

September 19, 2022

Presentation TCT 2022

TCT 680: Simultaneous Transcatheter Mitral and Tricuspid Approach in a Patient With Dextrocardia

Presenter: Vinicius Esteves

September 18, 2022

Presentation TCT 2022

TCT 650: Transcatheter Edge-to-Edge Valve Repair for Torrential Atrioventricular Valve Regurgitation in a Patient With Left Isomerism

Presenter: Lars Witte

September 18, 2022

Presentation TCT 2022

Predicting the Future of TEER in PMR: New Devices, Expanding Clinical Indications, and Combination Therapies

Presenter: Michael Rinaldi

September 18, 2022

Presentation TCT 2022

TEER in PMR: Current Technical Challenges, Anatomic Limitations, and Clinical Considerations

Presenter: Jason Rogers

September 18, 2022

Presentation TCT 2022

Next Generation Repair Technologies in the Mitral Field – Annuloplasty and Chordal Replacement

Presenter: Azeem Latib

September 18, 2022

Presentation TCT 2022

TCT 618: Turning the Tide with a Plug in the Hole: Successful transcatheter closure of post-infarct ventricular septal rupture in the context of myocardial infarction without obstructive coronary artery (MINOCA)

Presenter: Muthanna Abdul Halim

September 18, 2022

Presentation TCT 2022

The Argument for a TEER Trial in the FMR Space – CLASP IIF

Presenter: Brian Whisenant

September 18, 2022

Presentation TCT 2022

Echo Sees All – so what can we learn from echo in the CLASP Trials?

Presenter: Linda Gillam

September 18, 2022

Presentation TCT 2022

Insights from the CLASP IID Registry

Presenter: Jörg Hausleiter

September 18, 2022

Advertisement

TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

TCT 708: Balloon ring fracture and transcatheter aortic valve-in-valve implantation into a failed Direct Flow Medical prosthesis: in-vitro benchmark tests and in-vivo treatment

First-in-Human Transfemoral Tricuspid Valve Replacement With an Innovative Transcatheter Heart Valve Replacement System (TriCares TOPAZ)

Residual MR Post-TEER: Predictors of Long Term Success (and Late Failure)

Tailoring TEER: Imaging for Clip Selection and Technical Approaches (Based Upon Anatomic Considerations)

Two-Stage Transcatheter Tricuspid Annuloplasty: Technology Description and First Human Case Demonstrating Concept Validation (Cardiac Implants)

My Personal Step-by-Step Imaging Algorithm for TEER Planning and Procedural Guidance

TEER Planning: Real-World Situations Where Multi-Modality Imaging Is Recommended (Case-Based)

TCT 423: Effect of low versus high mitral valve gradients on outcomes of functional and degenerative mitral valve disease post transcatheter edge to edge repair.

Keynote Lecture: The Future of Diagnostic Imaging Modalities (Intra- and Extra-Vascular) and Implications for Transcatheter Therapies

TCT 680: Simultaneous Transcatheter Mitral and Tricuspid Approach in a Patient With Dextrocardia

TCT 650: Transcatheter Edge-to-Edge Valve Repair for Torrential Atrioventricular Valve Regurgitation in a Patient With Left Isomerism

Predicting the Future of TEER in PMR: New Devices, Expanding Clinical Indications, and Combination Therapies

TEER in PMR: Current Technical Challenges, Anatomic Limitations, and Clinical Considerations

Next Generation Repair Technologies in the Mitral Field – Annuloplasty and Chordal Replacement

TCT 618: Turning the Tide with a Plug in the Hole: Successful transcatheter closure of post-infarct ventricular septal rupture in the context of myocardial infarction without obstructive coronary artery (MINOCA)

The Argument for a TEER Trial in the FMR Space – CLASP IIF

Echo Sees All – so what can we learn from echo in the CLASP Trials?

Insights from the CLASP IID Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content